Ghrelin Levels in Obesity and Anorexia Nervosa: Effect of Weight Reduction or Recuperation
Overview
Affiliations
Objective: To study the influence of dietary intervention on plasma ghrelin levels in obese children and adolescents with anorexia nervosa (AN). Study design Prepubertal obese children (n=16) and 16 anorexic adolescents were studied at three different points: clinical diagnosis and after a reduction or recuperation of 25% and 50% of the initial BMI SD score. Controls included 21 Tanner growth stage 1 and 36 Tanner growth stage 5 subjects. We analyzed plasma ghrelin levels and their correlation with plasma levels of leptin, insulin, insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 1 (IGFBP-1), insulin-like growth factor binding protein 2 (IGFBP-2), insulin-like growth factor binding protein 3 (IGFBP-3), and integrated concentration of growth hormone (ICGH) before and after dietary intervention.
Results: At diagnosis, ghrelin levels were significantly decreased in obese children (52% of control levels) and significantly increased in adolescents with AN (164% of control levels). After dietary intervention, ghrelin increased in obese patients but without reaching control levels even after a 50% reduction in body mass index (BMI). In adolescents with AN, ghrelin levels normalized after a 25% increase in BMI. Ghrelin correlated negatively with the BMI and positively with IGFBP-1 levels in controls but not in obese patients or in patients with AN at diagnosis. The positive correlation between ghrelin and IGFBP-1 was recovered after dietary intervention.
Conclusions: Plasma ghrelin levels present opposite changes in obesity and AN after dietary intervention, suggesting that ghrelin is a good marker of nutritional status.
A Modular Customizable Ligand-Conjugate (LC) System Targeting Ghrelin -Acyltransferase.
Ford A, Taft C, Sprague-Getsy A, Carlson G, Mate N, Sieburg M Biomolecules. 2025; 15(2).
PMID: 40001510 PMC: 11852496. DOI: 10.3390/biom15020204.
Ghrelin and Leptin Concentrations in Patients after SARS-CoV2 Infection.
Kuliczkowska-Plaksej J, Jawiarczyk-Przybylowska A, Zembska A, Kolackov K, Syrycka J, Kaluzny M J Clin Med. 2023; 12(10).
PMID: 37240656 PMC: 10218943. DOI: 10.3390/jcm12103551.
Mohanraj J, DSouza U, Fong S, Karkada I, Jaiprakash H Int J Environ Res Public Health. 2022; 19(14).
PMID: 35886710 PMC: 9316401. DOI: 10.3390/ijerph19148862.
Diverse and Complementary Effects of Ghrelin and Obestatin.
Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y Biomolecules. 2022; 12(4).
PMID: 35454106 PMC: 9028691. DOI: 10.3390/biom12040517.
Lugilde J, Casado S, Beiroa D, Cunarro J, Garcia-Lavandeira M, Alvarez C Cells. 2022; 11(3).
PMID: 35159134 PMC: 8834077. DOI: 10.3390/cells11030324.